We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WH:NYSEWyndham Hotels & Resorts, Inc. Analysis

Data as of 2026-09-10 - not real-time

$69.78

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Wyndham Hotels & Resorts, Inc. trades at $69.78, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. It has lost 7.8% over the past 30 days. Relative strength is 34.7 — approaching oversold — and the MACD signal is bearish. Watch $68.54 as support and $78.46 as the nearer resistance level.
On valuation the read is fair — an earnings multiple of 25.3, absent a reliable peer benchmark. The average analyst target implies 40.1% above today's level. Revenue is contracting at 5.5% on a 14.6% profit margin. The 2.46% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 4 — moderate. With 30-day volatility of 26.3%, a beta of 0.59 and a maximum drawdown of 22.4%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Short, medium and long-term reads agree on sell, with conviction of 5/10.

Top Market Events

Updated Aug 13, 2026 0 PARSIPPANY, N.J., Aug. 13, 2026 /PRNewswire/ -- Wyndham Hotels & Resorts, Inc.   NYSE: WH...Why Wyndham Hotels & Resorts Stock Is Back In Focus Wyndham Hotels & Resorts WH is on investors’ radar after second...Track Wyndham Hotels & Resorts Inc live price, charts, and news.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 78.59
  • MACD momentum is negative

Medium Term

1–3 years
Cautious
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 78.59
  • Analyst targets imply +40.1% versus the current price

Long Term

> 3 years
Cautious
Model confidence: 5/10

Key Factors

  • Analyst targets imply +40.1% versus the current price
  • Revenue contracting at -5.5%
  • P/E ratio of 25.3

Key Metrics & Analysis

Financial Health

Revenue Growth-5.50%
Profit Margin14.60%
P/E Ratio25.3
ROE39.43%
ROA7.72%
Debt/Equity557.29
P/B Ratio10.9
Op. Cash Flow$371.0M
Free Cash Flow$362.4M

Technical Analysis

TrendBearish
RSI34.7
Support$68.54
Resistance$78.46
MA 20$73.61
MA 50$75.67
MA 200$78.59
MACDBearish
VolumeStable
Fear & Greed Index92.04

Valuation

Fair Value$26.45
Target Price$97.76
Upside/Downside40.10%
GradeFair
TypeBlend
Dividend Yield2.46%

Risk Assessment

Beta0.59
Volatility26.31%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.